Cytosorbents (CTSO) Competitors

Cytosorbents (NASDAQ:CTSO) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, community ranking, risk and dividends.

Do insiders & institutionals have more ownership in CTSO or DRTS?

32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 6.6% of Cytosorbents shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Do analysts rate CTSO or DRTS?

Cytosorbents currently has a consensus target price of $5.50, indicating a potential upside of 404.59%. Alpha Tau Medical has a consensus target price of $8.00, indicating a potential upside of 160.59%. Given Cytosorbents' higher possible upside, research analysts clearly believe Cytosorbents is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Alpha Tau Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is CTSO or DRTS more profitable?

Alpha Tau Medical has a net margin of 0.00% compared to Cytosorbents' net margin of -49.47%. Alpha Tau Medical's return on equity of -38.62% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-49.47%	-118.54%	-42.31%
Alpha Tau Medical	N/A	-38.62%	-29.89%

Which has more volatility and risk, CTSO or DRTS?

Cytosorbents has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Does the MarketBeat Community favor CTSO or DRTS?

Cytosorbents received 422 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 72.86% of users gave Cytosorbents an outperform vote while only 72.41% of users gave Alpha Tau Medical an outperform vote.

Company	Underperform	Outperform
Cytosorbents	Outperform Votes 443 72.86%	Underperform Votes 165 27.14%
Alpha Tau Medical	Outperform Votes 21 72.41%	Underperform Votes 8 27.59%

Does the media favor CTSO or DRTS?

In the previous week, Cytosorbents and Cytosorbents both had 1 articles in the media. Alpha Tau Medical's average media sentiment score of 1.89 beat Cytosorbents' score of 1.87 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Cytosorbents	Very Positive
Alpha Tau Medical	Very Positive

Which has better valuation & earnings, CTSO or DRTS?

Cytosorbents has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$35.33M	1.93	-$28.51M	-$0.28	-3.89
Alpha Tau Medical	N/A	N/A	-$29.16M	-$0.46	-6.67

Summary

Cytosorbents beats Alpha Tau Medical on 10 of the 16 factors compared between the two stocks.